Functional characterization of the T1799-1801del and A1799-1816ins BRAF mutations in papillary thyroid cancer

被引：65

作者：

Hou, Peng ^{[1
]}

Liu, Dingxie ^{[1
]}

Xing, Mingzhao ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, Dept Med, Baltimore, MD 21287 USA

来源：

CELL CYCLE | 2007年 / 6卷 / 03期

关键词：

papillary thyroid cancer; MAP kinase pathway; BRAF mutation; tumorigenesis;

D O I：

10.4161/cc.6.3.3818

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：377 / 379

页数：3

共 13 条

[1] Mutations of the BRAF gene in human cancer [J].

Davies, H ;

Bignell, GR ;

Cox, C ;

Stephens, P ;

Edkins, S ;

Clegg, S ;

Teague, J ;

Woffendin, H ;

Garnett, MJ ;

Bottomley, W ;

Davis, N ;

Dicks, N ;

Ewing, R ;

Floyd, Y ;

Gray, K ;

Hall, S ;

Hawes, R ;

Hughes, J ;

Kosmidou, V ;

Menzies, A ;

Mould, C ;

Parker, A ;

Stevens, C ;

Watt, S ;

Hooper, S ;

Wilson, R ;

Jayatilake, H ;

Gusterson, BA ;

Cooper, C ;

Shipley, J ;

Hargrave, D ;

Pritchard-Jones, K ;

Maitland, N ;

Chenevix-Trench, G ;

Riggins, GJ ;

Bigner, DD ;

Palmieri, G ;

Cossu, A ;

Flanagan, A ;

Nicholson, A ;

Ho, JWC ;

Leung, SY ;

Yuen, ST ;

Weber, BL ;

Siegler, HF ;

Darrow, TL ;

Paterson, H ;

Marais, R ;

Marshall, CJ ;

Wooster, R .

NATURE, 2002, 417 (6892) :949-954

[2] Frequent overexpression of cyclin D1 in sporadic pancreatic endocrine tumours [J].

Guo, SS ;

Wu, X ;

Shimoide, AT ;

Wong, J ;

Moatamed, F ;

Sawicki, MP .

JOURNAL OF ENDOCRINOLOGY, 2003, 179 (01) :73-79

[3]

Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO

[4]

2-1

[5] pp60v-src induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and Jun kinase pathways -: A role for cAMP response element-binding protein and activating transcription factor-2 in pp60v-src signaling in breast cancer cells [J].

Lee, RJ ;

Albanese, C ;

Stenger, RJ ;

Watanabe, G ;

Inghirami, G ;

Haines, GK ;

Webster, M ;

Muller, WJ ;

Brugge, JS ;

Davis, RJ ;

Pestell, RG .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (11) :7341-7350

[6] Biochemical and molecular characterization of the novel BRAFV599Ins mutation detected in a classic papillary thyroid carcinoma [J].

Moretti, S. ;

Macchiarulo, A. ;

De Falco, V. ;

Avenia, N. ;

Barbi, F. ;

Carta, C. ;

Cavaliere, A. ;

Melillo, R. M. ;

Passeri, L. ;

Santeusanio, F. ;

Tartaglia, M. ;

Santoro, M. ;

Puxeddu, E. .

ONCOGENE, 2006, 25 (30) :4235-4240

[7] Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis reveals a new mutation in metastasis [J].

Oler, G ;

Ebina, KN ;

Michaluart, P ;

Kimura, ET ;

Cerutti, J .

CLINICAL ENDOCRINOLOGY, 2005, 62 (04) :509-511

[8] Mitogen-activated protein kinase pathways [J].

Robinson, MJ ;

Cobb, MH .

CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (02) :180-186

[9] BRAF mutations are associated with some histological types of papillary thyroid carcinoma [J].

Trovisco, V ;

de Castro, IV ;

Soares, P ;

Máximo, V ;

Silva, P ;

Magalhaes, J ;

Abrosimov, A ;

Guiu, XM ;

Sobrinho-Simoes, M .

JOURNAL OF PATHOLOGY, 2004, 202 (02) :247-251

[10] Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF [J].

Wan, PTC ;

Garnett, MJ ;

Roe, SM ;

Lee, S ;

Niculescu-Duvaz, D ;

Good, VM ;

Jones, CM ;

Marshall, CJ ;

Springer, CJ ;

Barford, D ;

Marais, R .

CELL, 2004, 116 (06) :855-867

← 1 2 →